Amgen Inc - Asset Resilience Ratio

Latest as of December 2023: 11.26%

Amgen Inc (AMGN) has an Asset Resilience Ratio of 11.26% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See AMGN working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$10.94 Billion

Cash + Short-term Investments

Total Assets

$97.15 Billion

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (1999–2023)

This chart shows how Amgen Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Amgen Inc (AMGN) total assets.

Liquid Assets Composition Over Time

This chart breaks down Amgen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Amgen Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$10.94 Billion	11.26%
Total Liquid Assets	$10.94 Billion	11.26%

Asset Resilience Insights

Moderate Liquidity: Amgen Inc has 11.26% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Amgen Inc Industry Peers by Asset Resilience Ratio

Compare Amgen Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AstraZeneca PLC NYSE:AZN	Drug Manufacturers - General	0.06%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	0.06%
Organon & Co NYSE:OGN	Drug Manufacturers - General	4.46%
Aurora Optoelectronics Co Ltd SHG:600666	Drug Manufacturers - General	5.89%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	6.46%

Annual Asset Resilience Ratio for Amgen Inc (1999–2023)

The table below shows the annual Asset Resilience Ratio data for Amgen Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	11.26%	$10.94 Billion	$97.15 Billion	+8.69pp
2022-12-31	2.57%	$1.68 Billion	$65.12 Billion	+2.50pp
2021-12-31	0.08%	$48.00 Million	$61.16 Billion	-6.88pp
2020-12-31	6.96%	$4.38 Billion	$62.95 Billion	+2.15pp
2019-12-31	4.81%	$2.87 Billion	$59.71 Billion	-28.85pp
2018-12-31	33.67%	$22.36 Billion	$66.42 Billion	-13.71pp
2017-12-31	47.37%	$37.88 Billion	$79.95 Billion	+2.49pp
2016-12-31	44.89%	$34.84 Billion	$77.63 Billion	+6.83pp
2015-12-31	38.05%	$27.24 Billion	$71.58 Billion	+4.30pp
2014-12-31	33.76%	$23.30 Billion	$69.01 Billion	+10.17pp
2013-12-31	23.59%	$15.60 Billion	$66.12 Billion	-14.73pp
2012-12-31	38.31%	$20.80 Billion	$54.30 Billion	+10.29pp
2011-12-31	28.02%	$13.70 Billion	$48.87 Billion	-4.48pp
2010-12-31	32.50%	$14.13 Billion	$43.49 Billion	+5.86pp
2009-12-31	26.64%	$10.56 Billion	$39.63 Billion	+5.30pp
2008-12-31	21.34%	$7.78 Billion	$36.44 Billion	+6.54pp
2007-12-31	14.80%	$5.13 Billion	$34.64 Billion	+0.02pp
2006-12-31	14.78%	$4.99 Billion	$33.79 Billion	+3.12pp
2005-12-31	11.66%	$3.42 Billion	$29.30 Billion	-3.00pp
2004-12-31	14.65%	$4.28 Billion	$29.22 Billion	-1.72pp
2003-12-31	16.37%	$4.29 Billion	$26.18 Billion	+4.88pp
2002-12-31	11.50%	$2.81 Billion	$24.46 Billion	-19.13pp
2001-12-31	30.62%	$1.97 Billion	$6.44 Billion	-2.74pp
2000-12-31	33.37%	$1.80 Billion	$5.40 Billion	+3.88pp
1999-12-31	29.48%	$1.20 Billion	$4.08 Billion	--

pp = percentage points

About Amgen Inc

NASDAQ:AMGN USA Drug Manufacturers - General

Market Cap

$205.63 Billion

Market Cap Rank

#106 Global

#64 in USA

Share Price

$381.50

Change (1 day)

+1.10%

52-Week Range

$271.18 - $444.12

All Time High

$444.12